FULC FY 2025 Earnings — Fulcrum Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FULCFulcrum Therapeutics, Inc.

$436M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$85M

Net Income

-$75M

EPS (Diluted)

$-1.18

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$60M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$366M

Total Liabilities

$17M

Stockholders' Equity

$349M

Cash & Equivalents

$198M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$80M	-100.0%
Gross Profit	-$1M	$17M	-108.4%
Operating Income	-$85M	-$22M	-287.1%
Net Income	-$75M	-$10M	-670.0%